26.01.2017 12:00:00

Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services

MADISON, N.J. and NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with  Montefiore Health System (MHS) to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.

"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics.  "As part of our strategy to accelerate growth and drive operational excellence, Quest is collaborating with an increasing number of hospital partners, including leading academic institutions like Montefiore, which are looking to focus on their core business by taking advantage of our expertise, innovation and scale."  

Quest will perform a portion of low complexity diagnostic tests at its Teterboro, NJ lab facility. The remainder of the laboratory testing will continue to be done at Montefiore Hospitals under the direction of the Montefiore and Einstein Department of Pathology.

"Quest is a unique company committed to innovating new technologies and diagnostic capabilities," said Philip Ozuah, M.D., Ph.D., and Chief Operating Officer, Montefiore Health System. "Most importantly, this new venture  will allow Montefiore to maintain its laser focus on improving patient care and outcomes, while teaming up with a leader in the field who has access to the most sophisticated diagnostic equipment available."

About Quest Diagnostics 
Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.  Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com

About Montefiore Health System
Montefiore Health System is one of New York's premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children's Hospital at Montefiore, Burke Rehabilitation Hospital and close to 200 outpatient care sites. The advanced clinical and translational research at its' medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its' preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

Quest Diagnostics Contacts: 
Denny Moynihan, Quest Diagnostics (Media): 973-520-2800 
Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900

Montefiore Health System Contacts:   
Elizabeth Kaledin: 718-920-8173

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-partners-with-montefiore-health-system-to-deliver-high-value-innovative-laboratory-services-300397048.html

SOURCE Quest Diagnostics

Analysen zu Quest Diagnostics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Quest Diagnostics Inc. 145,30 0,10% Quest Diagnostics Inc.